(Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -100.88%-178 | 64.27%-7.43K | -59.72%7.33K | 92.39%-35.19K | -112.62%-52.84K | 105.16%20.25K | -63.45%-20.81K | 155.77%18.21K | -22.32%-462.27K | -54,121.74%-24.85K |
Net income from continuing operations | 21.37%-66.11K | 77.17%-98.47K | -120.95%-108.14K | -139.15%-663.1K | -21.49%-98.76K | -35.60%-84.08K | -404.46%-431.32K | -0.97%-48.94K | 24.82%-277.28K | -22.49%-81.29K |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---9.77K | ---- |
Asset impairment expenditure | ---- | ---- | ---- | --56.33K | ---- | ---- | ---- | ---- | --0 | ---- |
Remuneration paid in stock | --5.73K | -89.15%39.09K | --44.44K | --315.53K | ---44.79K | --0 | --360.32K | --0 | --0 | --0 |
Change In working capital | -42.30%60.2K | 3.50%51.96K | 5.78%71.03K | 246.13%256.06K | -48.06%34.39K | 131.61%104.33K | -31.02%50.2K | 324.18%67.15K | -59.28%-175.23K | 13.08%66.21K |
-Change in receivables | -211.94%-2.64K | 8.83%-2.9K | -71.93%4.98K | 331.98%14.82K | 40.78%-2.12K | -68.76%2.36K | 59.68%-3.18K | 814.86%17.76K | -334.46%-6.39K | -70.63%-3.57K |
-Change in prepaid assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -47.12%4.78K | --327 |
-Change in payables and accrued expense | -38.37%62.85K | 2.77%54.86K | 33.72%66.04K | 238.95%241.24K | -47.45%36.5K | 130.20%101.97K | -33.83%53.38K | 256.30%49.39K | -42.57%-173.62K | 14.53%69.46K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -100.88%-178 | 64.27%-7.43K | -59.72%7.33K | 92.39%-35.19K | -129.25%-52.84K | 104.88%20.25K | -359.32%-20.81K | 155.77%18.21K | -22.32%-462.27K | -50,202.17%-23.05K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -23.49K | -3.49K | 0 | 0 | ||||||
Net PPE purchase and sale | ---- | ---- | ---- | ---23.49K | ---- | ---- | ---- | ---- | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---- | ---- | ---- | ---23.49K | ---3.49K | ---- | ---- | ---- | --0 | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -95.42%20K | 33.70%436.89K | -4.76K | |||||||
Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --436.89K | ---4.76K |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | --20K | ---- | ---- | ---- | ---- | --0 | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | ---- | ---- | ---- | -95.42%20K | ---- | ---- | ---- | ---- | 33.70%436.89K | ---4.76K |
Net cash flow | ||||||||||
Beginning cash position | -96.31%1.39K | -84.89%8.82K | -96.30%1.49K | -38.72%40.17K | -44.37%37.82K | -8.21%37.57K | 77.39%58.37K | -38.72%40.17K | -43.83%65.55K | 3.77%67.97K |
Current changes in cash | -171.49%-178 | 64.27%-7.43K | -59.72%7.33K | -52.38%-38.68K | -30.63%-36.33K | -99.08%249 | -359.32%-20.81K | 155.77%18.21K | 50.38%-25.38K | -60,554.35%-27.81K |
End cash Position | -96.80%1.21K | -96.31%1.39K | -84.89%8.82K | -96.30%1.49K | -96.30%1.49K | -44.37%37.82K | -8.21%37.57K | 77.39%58.37K | -38.72%40.17K | -38.72%40.17K |
Free cash from | -100.88%-178 | 64.27%-7.43K | -59.72%7.33K | 87.31%-58.68K | -231.18%-76.33K | 104.88%20.25K | -359.32%-20.81K | 155.77%18.21K | -22.32%-462.27K | -50,202.17%-23.05K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data